Philippe Monteyne

Dr. Monteyne joined the company’s board of directors in 2015. Dr. Monteyne is a partner at Fund+, an open-ended venture capital fund for long term equity investments in innovative life sciences companies with a focus on Belgium. Dr. Monteyne has held senior positions at Smithkline Beecham, GSK, and Sanofi. He served as the head of global vaccine development at GSK for several years, and then served as a senior vice president, head of development and chief medical officer at GSK Rare Diseases from 2010 to 2012. He also served as vice president R&D France at Sanofi until early 2015. He is a member of the board directors of biotech companies in Belgium, France and Spain. He holds an MD degree and PhD in viral immunology, both from Université Catholique de Louvain, is a fully trained neurologist, and has also been trained in neuro-immunology at Pasteur Institute in Paris.